A detailed history of Snowden Capital Advisors LLC transactions in Organon & Co. stock. As of the latest transaction made, Snowden Capital Advisors LLC holds 19,640 shares of OGN stock, worth $311,294. This represents 0.01% of its overall portfolio holdings.

Number of Shares
19,640
Previous 17,475 12.39%
Holding current value
$311,294
Previous $361,000 3.88%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$18.65 - $23.03 $40,377 - $49,859
2,165 Added 12.39%
19,640 $375,000
Q2 2024

Aug 14, 2024

SELL
$17.45 - $21.96 $19,753 - $24,858
-1,132 Reduced 6.08%
17,475 $361,000
Q1 2024

May 15, 2024

BUY
$13.78 - $18.8 $50,476 - $68,864
3,663 Added 24.51%
18,607 $349,000
Q4 2023

Feb 14, 2024

BUY
$10.95 - $17.32 $15,811 - $25,010
1,444 Added 10.7%
14,944 $215,000
Q3 2023

Nov 14, 2023

SELL
$16.59 - $23.77 $118,419 - $169,670
-7,138 Reduced 34.59%
13,500 $234,000
Q2 2023

Aug 14, 2023

BUY
$19.27 - $24.63 $44,648 - $57,067
2,317 Added 12.65%
20,638 $429,000
Q1 2023

May 15, 2023

BUY
$21.42 - $32.08 $81,203 - $121,615
3,791 Added 26.09%
18,321 $430,000
Q4 2022

Feb 13, 2023

SELL
$23.31 - $28.61 $19,557 - $24,003
-839 Reduced 5.46%
14,530 $405,000
Q3 2022

Nov 09, 2022

BUY
$23.4 - $34.25 $20,053 - $29,352
857 Added 5.91%
15,369 $359,000
Q2 2022

Aug 12, 2022

SELL
$31.66 - $38.9 $50,656 - $62,240
-1,600 Reduced 9.93%
14,512 $489,000
Q1 2022

May 16, 2022

BUY
$30.45 - $39.36 $437,170 - $565,091
14,357 Added 818.06%
16,112 $562,000
Q4 2021

Feb 14, 2022

BUY
$28.67 - $37.13 $50,315 - $65,163
1,755 New
1,755 $53,000
Q3 2021

Feb 05, 2024

SELL
$28.63 - $35.64 $133,959 - $166,759
-4,679 Reduced 34.66%
8,821 $289 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.03B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Snowden Capital Advisors LLC Portfolio

Follow Snowden Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.